- Home
- BCML vs CLLS Comparison
BCML vs CLLS Comparison
Compare BCML & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCML
- CLLS
- Stock Information
- Founded
- BCML 2004
- CLLS 1999
- Country
- BCML United States
- CLLS France
- Employees
- BCML N/A
- CLLS N/A
- Industry
- BCML Major Banks
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- BCML Finance
- CLLS Health Care
- Exchange
- BCML Nasdaq
- CLLS Nasdaq
- Market Cap
- BCML 322.1M
- CLLS 240.2M
- IPO Year
- BCML N/A
- CLLS 2007
- Fundamental
- Price
- BCML $26.82
- CLLS $1.57
- Analyst Decision
- BCML
- CLLS Buy
- Analyst Count
- BCML 0
- CLLS 3
- Target Price
- BCML N/A
- CLLS $7.00
- AVG Volume (30 Days)
- BCML 31.7K
- CLLS 56.7K
- Earning Date
- BCML 01-23-2025
- CLLS 11-04-2024
- Dividend Yield
- BCML 2.00%
- CLLS N/A
- EPS Growth
- BCML N/A
- CLLS N/A
- EPS
- BCML 2.10
- CLLS N/A
- Revenue
- BCML $96,064,000.00
- CLLS $36,042,000.00
- Revenue This Year
- BCML N/A
- CLLS $271.02
- Revenue Next Year
- BCML $4.79
- CLLS $33.48
- P/E Ratio
- BCML $13.09
- CLLS N/A
- Revenue Growth
- BCML N/A
- CLLS 46.96
- 52 Week Low
- BCML $18.54
- CLLS $1.53
- 52 Week High
- BCML $30.13
- CLLS $3.55
- Technical
- Relative Strength Index (RSI)
- BCML 37.79
- CLLS 27.91
- Support Level
- BCML $28.53
- CLLS $1.85
- Resistance Level
- BCML $29.81
- CLLS $2.09
- Average True Range (ATR)
- BCML 0.96
- CLLS 0.09
- MACD
- BCML -0.37
- CLLS -0.04
- Stochastic Oscillator
- BCML 19.90
- CLLS 0.00
About BCML BayCom Corp
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.